It has been another busy week for many of Australia's top brokers. This has led to the release of a number of broker notes.
Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone right now:
Boss Energy Ltd (ASX: BOE)
According to a note out of Bell Potter, its analysts have retained their buy rating on this uranium producer's shares with a reduced price target of $4.70. The broker highlights that Boss Energy is one of the most shorted shares on the Australian share market. However, it believes that short sellers continuing to hold short positions at this level run the risk of being squeezed. This is because the broker doesn't believe that its production cost update will be as bad as feared and feels that any potential increase is more than priced in now. So, with its shares screening as incredibly cheap against North American peers, Bell Potter suspects that its shares could re-rate significantly if things go to plan. The Boss Energy share price is trading at $2.45 this morning.
Pro Medicus Limited (ASX: PME)
A note out of Goldman Sachs reveals that its analysts have retained their buy rating on this health imaging technology company's shares with an improved price target of $278.00. According to the note, the broker believes that Pro Medicus is one of Australia's best global growth companies. It feels that further Visage adoption is a matter of when, not if. In light of this, Goldman forecasts a strong increase in the value and cadence of contract wins over time. And while Pro Medicus is not cheap, trading on 114x FY26E EV/EBITDA, the broker believes that this is justified due to its revenue/margin outlook, unique cloud offering, and significant long-term opportunity. The Pro Medicus share price is trading at $251.69 on Friday.
Readytech Holdings Ltd (ASX: RDY)
Analysts at Morgans have initiated coverage on this mission-critical software company's shares with an add rating and $3.74 price target. According to the note, the broker has been pleased with Readytech's performance this year and believes that the strong form can continue for the next few years. So much so, it is forecasting double digit growth each year over the period. Despite this, it notes that its shares are trading a huge discount to historical multiples. Morgans feels this has created a compelling buying opportunity. The Readytech share price is fetching $2.94 at the time of writing.
